improving the qol of patients with multiple myeloma treated with car-t therapy
Published 1 year ago • 81 plays • Length 1:43Download video MP4
Download video MP3
Similar videos
-
1:12
optimizing car-t therapy for patients with multiple myeloma in the real-world
-
2:57
strategies to optimize car-t therapy in myeloma: bringing car-t into earlier lines
-
0:48
selecting patients with multiple myeloma for car-t therapy
-
4:14
challenges with the real-world use of car-t therapy in multiple myeloma
-
1:22
the potential use of car-t therapy following autologous transplantation in multiple myeloma
-
11:17
car-t cells: engineered cancer killers
-
5:10
what is multiple myeloma? - animated
-
![simplifying gmp car t and car nk cell therapy manufacturing processes [webinar]](https://i.ytimg.com/vi/OThRND_fNRc/mqdefault.jpg)
1:04:15
simplifying gmp car t and car nk cell therapy manufacturing processes [webinar]
-
4:49
factors to predict the outcomes of patients with r/r myeloma treated with car-t therapy
-
2:49
novel strategies to optimize car-t therapy in myeloma
-
2:23
improving car t-cell therapy for myeloma
-
1:38
how to optimize access to car-t cell therapies in multiple myeloma
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
4:04
overcoming challenges in car t-cell therapy for multiple myeloma
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma
-
2:41
cell avidity as a predictor of t-cell efficacy
-
1:24
improving manufacturing of car-t cells in multiple myeloma: phe885 & other novel constructs
-
2:46
managing patients with high-risk myeloma
-
1:38
challenges of car-t therapy in the real-world setting
-
3:33
determining the optimal sequencing of bispecifics and car-t cells in patients with myeloma
-
1:42
optimal sequencing of immunotherapies to improve outcomes for patients with multiple myeloma
-
9:58
the management & optimization of car t-cell therapy in myeloma